We present a case of a 79-year-old man with prostate cancer with biochemical recurrence after radical prostatectomy and hormonal therapy. 68 Ga-prostate-specific membrane antigen positron emission tomography/computed tomography (PSMA PET/CT) was performed to look for recurrent disease, and a solitary metastasis to the left testicle was detected. This case report highlights the importance of 68 Ga-PSMA PET/CT in detecting unusual metastatic lesions from prostate cancer in patients with biochemical recurrence.
Introduction
68 Ga-prostate-specific membrane antigen positron emission tomography/computed tomography (PSMA PET/CT) has proved superiority compared to other modalities; both regarding sensitivity and specificity for detecting lesions in patients with a biochemically recurrent prostate cancer, [1] this, in turn, has prompted a significant change in management of these patients. [2] 
Case Report
We present a case of a 79-year-old man with prostate cancer who initially presented with prostate-specific antigen (PSA) level of 7 ng/ml, suspicious digital rectal examination, and positive transrectal ultrasound biopsy. The patient underwent radical prostatectomy 17 years ago, and histopathologic evaluation showed Gleason's score 7 (4 + 3) adenocarcinoma. PSA level had dropped following surgery to 0.02 ng/mL, and the patient was maintained on hormonal therapy with triptorelin.
The patient presented with rising PSA levels from 0.47 ng/ml to 3.9 ng/ml in a span of 3 months, in keeping with biochemical recurrence.
68 Ga-PSMA PET/CT was performed and showed a single abnormal radiotracer-avid focal area localized to the left testicle with maximum standardized uptake value 9.3, and a concern for metastasis was raised [ Figure 1 ]. This was further evaluated with ultrasound and magnetic resonance imaging examinations, confirming the presence of focal lesion [ Figure 2 ].
The patient underwent bilateral orchiectomy, and histopathologic evaluation revealed metastatic prostatic adenocarcinoma to the left testicle.
Discussion
Metastatic disease to testicles from solid tumors is very rare; a retrospective autopsy study of 738 patients with solid malignant neoplasms found metastasis to testicles in 0.68% of patients. [3] Prostate cancer is the most common culprit, which was found in 35.4% of these patients as per Haupt et al. [4] Excluding autopsy cases and incidental tumors in therapeutic orchiectomies, metastatic carcinomas to the testicles are usually solitary and unilateral, which may simulate primary neoplasms. [5] Prolongation of the course of prostate cancer due to progressive hormonal therapies may have increased the incidence of metastatic disease to the testicles because they have more time to develop. [6] To the best of our knowledge, there are only two cases of solitary metastatic prostate cancer to the testicle diagnosed by 68 Ga-PSMA PET/CT and reported in the literature. [7, 8] This case report highlights the importance of 68 Ga-PSMA PET/CT in detecting unusual metastatic lesions from prostate cancer in patients with biochemical recurrence.
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